TOPIC

healthcare

富士フイルムホールディングス株式会社FY2026

Is Fujifilm really a photography company?

18.7%Imaging share of group revenue (site calculation)
¥1.099tnHealthcare revenue
12 / 16 unitsNew U.S. Bio CDMO units sold before operation
What emerges

Fujifilm did not simply abandon photography and become a different company. It repeatedly transferred chemistry, thin-film, imaging and precision-processing capabilities built for photography into healthcare, Bio CDMO and semiconductor materials. Imaging remains highly profitable; what changed most is how far its technology base travels.

See the company through the numbers →